Brief: Race Oncology Executes Contracts To Commence Observational Cardioprotection Breast Cancer Trial
13/03/2023 01:11
March 13 (Reuters) - Race Oncology Ltd RAC.AX :
* EXECUTES CONTRACTS TO COMMENCE OBSERVATIONAL
CARDIOPROTECTION
BREAST CANCER TRIAL
Source text for Eikon: ID:nASXzb7gc
Further company coverage: RAC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Racura Oncology
See all newsAustralia's Racura Oncology jumps most in a month after raising $24 million
Brief: Racura Oncology Says Emerging Companies Specialist Invests In Racura
Brief: Racura Oncology Announces Positive Safety Review Committee Recommendation In Ongoing Cpacs Clinical Trial
Australia's Racura Oncology gains on Purdue University cancer study collab
Brief: Racura Oncology Receives Governance Approval For Harness-1 Phase 1 Trial Of Rc220